Clinical Cancer Research · 2008 · 166 citations · 38 references
MedicineCancer BiologyOncologyApoptosisMetastasisMolecular OncologyApoptosis In CancerCancer Cell SignalingCancer ProgressionMalignant NeoplasmsOncogenic Signaling PathwaysSignal Transduction In CancerApoptosis Signaling In CancerCancer Metastasis MechanismsChemotherapy-induced ApoptosisMelanoma ProgressionPrognostic Marker AssessmentPrognostic Marker EvaluationTissue MicroarraysTumor Cell Proliferation
PURPOSE: The epidermal growth factor receptor family member HER3 is overexpressed in diverse human cancers and has been associated with poor prognosis in breast, lung, and ovarian cancer. However, the relevance of HER3 with regard to its prognostic significance and function in primary melanoma and metastases remains largely elusive. EXPERIMENTAL DESIGN: HER3 protein expression was analyzed immunohistochemically using tissue microarrays of 130 primary melanoma and 87 metastases relative to established clinical variables. The possibility of an influence of HER3 on melanoma cell proliferation, migration, invasion, and chemotherapy-induced apoptosis was studied in human melanoma cell lines. RESULTS: We show that HER3 is frequently expressed in malignant melanoma and metastases at elevated levels. High HER3 expression may serve as a prognostic marker because it correlates with cell proliferation, tumor progression, and reduced patient survival. Suppression of HER3 expression by RNA interference reduces melanoma cell proliferation, migration, and invasion in vitro. In addition, down-regulation of HER3 synergistically enhances dacarbazine-induced apoptosis. Moreover, monoclonal antibodies specific for the extracellular portion of HER3 efficiently block heregulin-induced proliferation, migration, and invasion of melanoma cell lines. CONCLUSION: Our results provide novel insights into the role of HER3 in melanoma and point out new possibilities for therapeutic intervention.
38
Tissue microarrays for high-throughput molecular profiling of tumor specimens
Juha Kononen, Lukas Bubendorf, Anne Kallionimeni et al. · Nature Medicine · 1998 · 4.1K citations
A rapid in vitro assay for quantitating the invasive potential of tumor cells.
Adriana Albini, Yukihide Iwamoto, Kleinman Hk et al. · PubMed · 1987 · 1.8K citations
Medicine, Cell Biology, Oncology +16
Rheb Binds and Regulates the mTOR Kinase
Yenshou Lin, Sara Ortiz-Vega, Kazuyoshi Yonezawa et al. · Current Biology · 2005 · 990 citations · Full text
Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3
Natalia Sergina, Megan Rausch, Donghui Wang et al. · Nature · 2007 · 989 citations · Full text
Medicine, Cancer Biology, Oncology +14